Atossa Genetics
Price & Volume
Stats
See more52W Range | $3.76-$19.35 |
Market Cap | $42.5M |
Shares Short | 327,683 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.04 |
News
See moreYahoo Finance • 18 days ago
Atossa Therapeutics GAAP EPS of -$4.04 misses by $0.22
Yahoo Finance • 25 days ago
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
Yahoo Finance • 8 months ago
Advanced Authentication Market Outlook Report 2025-2029: Advanced Authentication Market to Surge by USD 75.57 Billion from 2024-2029, Driven by Online Transactions Boom
Yahoo Finance • 8 months ago
Atos posts H1 drop in orders and revenue on weak demand, tough market backdrop
About
CEO | Dr. Steven C. Quay FCAP, M.D., Ph.D. |
Address | 107 Spring Street, Seattle, WA, United States, 98104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 16 |
